We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2433:TSEZhongtian Construction (Hunan) Group Limited Analysis

Data as of 2026-06-17 - not real-time

NT$44.35

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Huxen Corporation trades at a price that exceeds its discounted cash‑flow estimate while its price‑to‑earnings multiple sits comfortably below the industry average, suggesting a potential overvaluation from a pure valuation perspective. The stock’s technical profile is bearish – the 20‑day moving average lies beneath the 50‑day average, the price is hovering near a short‑term resistance level, and volume is on a downtrend, all pointing to limited upside in the near term.
On the fundamentals side, the company delivers a very high dividend yield supported by a payout ratio close to 100%, which raises questions about dividend sustainability given modest free cash flow. Low beta indicates little market‑wide price sensitivity, but the sector (industrial equipment) carries medium‑level cyclical risk, and Taiwan‑specific geopolitical factors add a medium geographic risk. Investors should weigh the attractive income against the valuation gap and the bearish technical outlook.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (price below 20‑day SMA, decreasing volume)
  • Current price above DCF fair value
  • High dividend payout ratio threatens sustainability

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation gap offers potential price correction opportunity
  • Attractive dividend yield if sustainability improves
  • Stable cash position but modest revenue growth

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Fundamentally a value play with low market beta
  • Sector exposure to industrial cycles
  • Potential for dividend policy adjustment to enhance sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth0.60%
Profit Margin16.16%
P/E Ratio14.6
ROE11.68%
ROA3.52%
Debt/Equity63.31
P/B Ratio2.1
Op. Cash FlowNT$1.2B
Free Cash FlowNT$318.8M
Industry P/E31.2

Technical Analysis

TrendBearish
RSI50.7
SupportNT$42.80
ResistanceNT$45.20
MA 20NT$43.93
MA 50NT$44.89
MA 200NT$47.01
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5

Valuation

Fair ValueNT$34.76
GradeOvervalued
TypeValue
Dividend Yield6.81%

Risk Assessment

Beta-0.02
Volatility11.32%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.